Fermented Mammalian Milk Peptides for Animal Immune Support
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nutritional compositions for domestic animals lack effective immune system enhancement and digestive health support, particularly for immature mammals, and have limited shelf stability and administration convenience.
Innovation Solution
Development of novel nutritional compositions using Przewalski bacterial cultures for fermentation of mammalian milk or colostrum, which produce bioactive peptides and components that enhance immune function, gut health, and reduce anxiety in animals, with formulations suitable for individual and herd administration and stable shelf life.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional fermentation processes are used with naturally occurring yeasts and bacteria, then the process is simple and cost-effective, but the product quality varies and shelf life is limited
Solution Approach 1:
The patent applies parameter changes by controlling fermentation conditions (temperature, pH, time, oxygen levels) and selecting specific bacterial strains to transform the unpredictable natural fermentation process into a controlled one that produces consistent quality products with extended shelf life while maintaining manufacturing simplicity
2Stability of the object's composition
If controlled fermentation is implemented to ensure consistent quality, then product stability improves, but manufacturing complexity increases
Solution Approach 1:
The patent employs self-service principles by using selected bacterial strains that naturally produce beneficial effects (probiotic action, pathogen inhibition) and by formulating products with inherent stability features, reducing the need for complex external control systems while maintaining consistent quality
3Reliability
If fermented milk products are produced with high bacterial activity, then health benefits are enhanced, but shelf life decreases due to continuing bacterial action
Solution Approach 1:
The patent applies preliminary action by pre-selecting specific bacterial strains with desirable characteristics and pre-controlling fermentation conditions to achieve the desired probiotic effect, then stabilizing the product to prevent further bacterial activity, thus preserving health benefits while extending shelf life
4Measurement precision
If nutritional compositions are formulated for individual animal administration, then dosing precision is improved, but administration convenience decreases
Solution Approach 1:
The patent applies universality by formulating nutritional compositions that can serve multiple functions and be administered through various routes (oral, topical, injection) and in different forms (liquids, powders, pellets), allowing the same core product to accommodate both precise dosing requirements and convenient mass administration to herds
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions effectively strengthen the immune system, promote growth, and improve digestive health, reducing anxiety and preventing conditions like Irritable Bowel Syndrome and ulcers, while being stable and convenient for commercial production and use.
Implementation Method 1
The nutritional products and supplements are prepared by unique milk fermentation processes
Data Source
AI summary
Novel nutritional compositions and methods for their manufacture, administration and use are disclosed. The nutritional compositions of the present invention are useful for the feeding of immature mammals, particularly those used for food, and/or performance animals, such as horses, and for companion animals, such as dogs and cats. The nutritional compositions and supplements of the present invention are effective in supporting the growth and health of the immature mammal, in supporting and stimulating its immune system, and in mitigating undesirable infections and other. Additionally, particular fractions of the unique peptides produced by the disclosed methods can be separated and utilized as therapeutic agents.